| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
Mayo Clinic Laboratories is leading an evolution in neurology testing. Propelled by ongoing discoveries of clinically relevant biomarkers, our laboratory scientists integrate research findings into test development and implementation. Collaboration between our labs and the clinical practice at Mayo Clinic supports development of clinically validated testing that delivers actionable answers for patients.
“The ability of Mayo Clinic to make discoveries and translate these into solutions for our patients is critical to our mission.”
John Mills, Ph.D., co-director, Neuroimmunology Laboratory
OUR DIFFERENCE
The latest
For many, the path to a correct diagnosis can be long and filled with uncertainty. This story highlights the resilience and determination of one patient who navigated a complex medical journey to find answers and hope at Mayo Clinic. The patient asked to remain anonymous for personal privacy reasons.
A study by Mayo Clinic researchers found that most patients with suspected spinal cord inflammation of unknown cause have an alternative, specific diagnosis. The research is published in Neurology, the medical journal of the American Academy of Neurology.
Discovery's Edge, Mayo Clinic's research magazine, recently highlighted how new tests are developed in Mayo Clinic’s Neuroimmunology Laboratory.
This week’s Research Roundup highlights the association between microinfarcts and blood pressure trajectories.
Mayo Clinic has launched a first-in-the-U.S. clinical test that will help patients who recently have been diagnosed with an inflammatory demyelinating disease but may be unsure of the exact disorder.
This week’s Research Roundup highlights rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease.
This week’s Research Roundup highlights rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease.
This week’s Research Roundup highlights urinary extracellular vesicles of podocyte origin and renal injury in preeclampsia.
This week’s Research Roundup highlights expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG positive patients.
This week’s Research Roundup highlights the single-nephron glomerular filtration rate in healthy adults.
This week’s Research Roundup highlights the management of diffuse low-grade gliomas in adults.
The algorithm can be viewed here.
Greg Widseth was suddenly hit by a rare disease that prompted his immune system to attack his brain cells, resulting in as many as 60 seizures a day. Special blood and spinal fluid tests developed by Mayo Medical Laboratories confirmed that Widseth had antibodies known to target certain brain cells.